About Cureous
Cureous is a Healthcare company based in Bengaluru (India) founded in 2020 by Asish Mohandas. AI-enabled platform for patient engagement and care coordination is developed. Cureous has raised $405.01 thousand across 4 funding rounds from investors including IKP Knowledge Park, Firstport Capital and Chandrashekhar Surendranath. Cureous was last valued at $3.1 million in April 2025. Its chief executive, as recorded, is Asish Mohandas. Its Indian entity Cureous Labs Private Limited reported revenue of ₹73.1 Lakh. Cureous offers products and services including Intelligent Automatic Patient Lateral Turning System, Patient Lateral Turning & Pressure Relieving System, and Ergonomic Patient Turning & Repositioning System. Its focus areas include Life Sciences, Hospital Equipment, Hospital Infrastructure and Patient Mobility.
Company details
Developer of AIenabled patient engagement and care coordination platform. The platform facilitates automated outreach, appointment scheduling, and followup communications using conversational AI agents. It supports secure integration with healthcare systems, patient data repositories, and clinical workflows to deliver personalized engagement at scale. The system enables triage guidance, reminders, feedback collection, and resource navigation without manual intervention. Robust monitoring and logging capabilities offer visibility into patient interactions, engagement metrics, and operational performance. The platform supports configurable messaging channels across voice, SMS, and chat interfaces and enables segmentbased targeting and content customization. Collaboration tools allow administrators to design, adjust, and manage engagement flows. The solution is tailored for healthcare providers seeking efficient, automated care coordination and patient communication workflows.
- Headquarters Bengaluru, India
- Founders Asish Mohandas
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website cureous.in
- Social LinkedIn X
- Legal Name Cureous Labs Private Limited
- Date of Incorporation 05 Dec, 2019
- Jurisdiction Palakkad, Kerala, India
- Annual Revenue₹73.1 Lakh
FY 2024 · +41% YoY
- Net Loss-₹4.1 Lakh
FY 2024 · -6% margin
- EBITDA-₹3.4 Lakh
FY 2024 · -5% margin
- Total Equity Funding$405.01K (USD)
in 4 rounds
- Latest Funding Round$189.4K (USD), Seed
Aug 2025
- InvestorsIKP Knowledge Park
& 23 more
Associated legal entities of Cureous
Cureous operates through Cureous Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cureous Labs Private Limited CIN U33125KL2019PTC060649 | Active | 05 Dec 2019 | Palakkad, Kerala | ₹0.7 Cr | 2 | View details |
Products & Services of Cureous
Cureous offers a comprehensive portfolio of products and services, including Intelligent Automatic Patient Lateral Turning System, Patient Lateral Turning & Pressure Relieving System, and Ergonomic Patient Turning & Repositioning System.
Automates patient repositioning to prevent bedsores in homes and palliatives.
Provides turning and relief for patients in hospital environments.
Facilitates easy patient adjustment in various care settings.
Funding Insights of Cureous
Cureous has successfully raised a total of $405.01K across 4 strategic funding rounds. The most recent funding activity was a Seed round of $189.4 thousand completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $405,005
- Total Rounds 4
- Last Round Seed — $189,401
- First Round $35,954
(Apr 2024)
- Investors Count 24
All 4 funding rounds of Cureous with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2025 | $189,401 | Seed | – | Inflection Point Ventures | |
| Apr 2025 | $150,025 | Seed | $3.1M | Firstport Capital | |
| Nov 2024 | $29,625 | Seed | $3.02M | IKP Knowledge Park | – |
| Apr 2024 | $35,954 | Seed | $••••• | IKP Knowledge Park | – |
| Date | Valuation | Stage |
|---|---|---|
| Apr 2025 | $3.1M | •••••••• |
| Nov 2024 | $3.02M | •••••••• |
| Apr 2024 | $••••• | •••••••• |
Full valuation and stage history of Cureous
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $3.1M (Apr 2025). 24 investors in total: 4 institutional and 20 angel.
Investors in Cureous
Cureous has secured backing from 24 investors, including venture fund and angel investors. Prominent investors backing the company include IKP Knowledge Park, Firstport Capital and Chandrashekhar Surendranath.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Med-tech startups are incubated by IKP Knowledge Park. | 1999 | ikpknowledgepark.com | Hyderabad, India | |
Venture capital investment in tech-startups | firstportcapital.tcc.mode | Gurugram, India | ||
Investments are made in early-stage tech startups across sectors. | ipventures.in | Gurugram, India | ||
Investments are made in early and growth stage tech startups. | anthillventures.com | Hyderabad, India | ||
CS Chandrashekhar Surendranath | unknown_0c5b548e9b74496a9 | |||
SB Shainesh Baheti | unknown_4b901b28f902467ea | |||
MK Mohit Kumar Shankla | unknown_d27112a7df84467ea | |||
SB Sanjay B Shah | unknown_68d24ffe975a424db | |||
PD Pranshu Dwivedi | unknown_59094029306f47879 | |||
SS Sarvadada Swamy | unknown_73cc901ce2e84dd78 |
Investor details for Cureous
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Cureous Labs Private Limited (Cureous)
Cureous Labs Private Limited is the primary company behind Cureous. The board of Cureous Labs Private Limited currently have 2 directors; the longest-serving is Asish Mohandas, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Asish Mohandas DIN 08630904 | Managing Director | 05 Dec 2019 | 6 yrs 10 mo | Cureous Labs Private Limited |
| Kaithakode Radharani DIN 08630905 | Director | 05 Dec 2019 | 6 yrs 10 mo | Cureous Labs Private Limited |
People of Cureous
1 people are tracked at Cureous (1 in leadership).
| Name | Role | Group |
|---|---|---|
| Founder & CEO | Leadership |
Complete people profiles for Cureous
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Cureous
Figures of Cureous Labs Private Limited, the primary company behind Cureous, for FY 2024. Revenue was ₹73.1 Lakh (+41% year on year). Net loss was -₹4.1 Lakh (-6% margin). EBITDA was -₹3.4 Lakh (-5% margin). Revenue has grown at a compounded annual rate of +54% over three years.
- ₹73.1 LakhRevenue · FY 2024 · +41% YoY
- -₹4.1 LakhNet loss · -6% margin
- -₹3.4 LakhEBITDA · -5% margin
- ₹1.7 LakhPaid-up capital
- +54%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Cureous Labs Private Limited are on its company page.
Detailed financial statements for Cureous
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Cureous
4 dated milestones of Cureous across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Cureous is founded.
- Funding First funding round of $36K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $189K.
Web traffic of Cureous
The website of Cureous (cureous.in) receives about 1.4K visits a month.
- Monthly visits1.4K
▲ 25.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cureous
Complete news archive for Cureous
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cureous
Cureous was founded in 2020 and raised its 1st funding round 4 years after it was founded.
Cureous is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Asish Mohandas is the CEO of Cureous, as recorded in our data. They have also founded this company.
Cureous is a funded company, having raised a total of $405.01K across 4 funding rounds to date. The company's 1st funding round was a Seed of $35.95K, raised on Apr 2024.
The primary company behind Cureous, Cureous Labs Private Limited, reported revenue of ₹73.1 Lakh for FY 2024, up 41% year on year.
Developer of AIenabled patient engagement and care coordination platform. The platform facilitates automated outreach, appointment scheduling, and followup communications using conversational AI agents. It supports secure integration with healthcare systems, patient data repositories, and clinical workflows to deliver personalized engagement at scale. The system enables triage guidance, reminders, feedback collection, and resource navigation without manual intervention. Robust monitoring and logging capabilities offer visibility into patient interactions, engagement metrics, and operational performance. The platform supports configurable messaging channels across voice, SMS, and chat interfaces and enables segmentbased targeting and content customization. Collaboration tools allow administrators to design, adjust, and manage engagement flows. The solution is tailored for healthcare providers seeking efficient, automated care coordination and patient communication workflows.
Cureous offers Intelligent Automatic Patient Lateral Turning System, Patient Lateral Turning & Pressure Relieving System, and Ergonomic Patient Turning & Repositioning System.
Cureous has 24 investors. Key investors include IKP Knowledge Park, Firstport Capital, Chandrashekhar Surendranath, Shainesh Baheti, and Mohit Kumar Shankla.
The valuation of Cureous is $3.1M as of Apr 2025.
Cureous operates through Cureous Labs Private Limited.
The legal entities of Cureous currently have 2 directors, including Asish Mohandas, Kaithakode Radharani.